Learn more

BEIJING DINGCHENG TAIYUAN BIOTECHNOLOGY CO LTD

Overview
  • Total Patents
    42
  • GoodIP Patent Rank
    35,927
  • Filing trend
    ⇧ 1300.0%
About

BEIJING DINGCHENG TAIYUAN BIOTECHNOLOGY CO LTD has a total of 42 patent applications. It increased the IP activity by 1300.0%. Its first patent ever was published in 2015. It filed its patents most often in China. Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are QILU CELL THERAPY TECH CO LTD, PACT PHARMA INC and FLASH THERAPEUTICS.

Patent filings in countries

World map showing BEIJING DINGCHENG TAIYUAN BIOTECHNOLOGY CO LTDs patent filings in countries
# Country Total Patents
#1 China 42

Patent filings per year

Chart showing BEIJING DINGCHENG TAIYUAN BIOTECHNOLOGY CO LTDs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Jiao Shunchang 39
#2 Zhang Rong 39
#3 Zhou Zishan 24
#4 Wang Haiyan 12
#5 Xie Jiasen 12
#6 Zhang Tianfu 12
#7 Li Yingying 9
#8 Chen Xiaobin 7
#9 Wu Ziming 6
#10 Yuan Han 6

Latest patents

Publication Filing date Title
CN112251413A Preparation method, cell and application of cell for transmembrane expression of novel coronavirus antigen
CN111892656A Anti-human c-Met human-mouse chimeric monoclonal antibody and application thereof
CN111848797A Single-chain antibody targeting c-Met, chimeric antigen receptor, recombinant vector, CAR-T cell and application
CN111606996A Mouse monoclonal antibody targeting 4D5, and preparation method and application thereof
CN111393504A Liver cancer antigen composition, application thereof and cytotoxic T lymphocyte
CN111333698A Breast cancer target antigen combination, CTL cell cultured by breast cancer target antigen combination stimulation and application thereof
CN111333711A Lung cancer antigen composition, application thereof and cytotoxic T lymphocyte
CN111363008A Fallopian tube cancer target antigen combination, CTL cell cultured by fallopian tube cancer target antigen combination stimulation and application of CTL cell
CN111363009A Rectal cancer target antigen, CTL cell cultured by rectal cancer target antigen stimulation and application thereof
CN111330002A General DC cell vaccine of targeted coronavirus, preparation method and application thereof
CN110951694A Preparation method of autologous trophoblast and culture method of SNK cells
CN110904052A Culture method of SNK cells
CN111088270A Gene, vector and method for preparing immortalized dendritic cell and immortalized dendritic cell
CN111041048A Preparation method of limited-generation trophoblast and culture method of SNK cells
CN110863000A Gene and transfection vector for transfecting NK cell
CN110478472A PD-1 sealer and its application
CN110551198A Lung cancer antigen composition, application thereof and cytotoxic T lymphocyte
CN110396131A A kind of Chimeric antigen receptor, recombinant vector, recombinant cell and the application of ErbB2 single-chain antibody, targeting people ErbB2
CN110396130A A kind of anti-human ErbB2 monoclonal antibody 10A6 of mouse, encoding gene and its preparation method and application
CN110172480A Dual anti-original epitope fusion genetic recombination slow virus carrier, antigen presenting cell and CTL cell and its construction method and application